Extracorporeal Membrane Oxygenation in a Patient with Biliary Atresia: Case and Review of Extracorporeal Life Support Organization Data
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jan 2018 · 1 min read
In brief
In brief
This case report describes the first documented use of pretransplant ECMO in an infant with biliary atresia complicated by portopulmonary hypertension and cardiomyopathy. Combined extracorporeal life support and hepatic dialysis successfully bridged the patient to liver transplantation, demonstrating a novel application of advanced life support in pediatric end-stage liver disease.
Written by the GCMD Library team from the article.
Statements in this article
Biliary atresia is a newborn cholangiopathy that may lead to portopulmonary hypertension and cirrhosis-induced cardiomyopathy while awaiting liver transplantation.
Extracorporeal life support and hepatic toxin filtration are life-saving interventions that provide cardiopulmonary support and hepatic dialysis to allow resolution of a child's illness.
A combination of extracorporeal life support and hepatic toxin filtration can be used to bridge an infant with biliary atresia to transplantation.
Review of the Extracorporeal Life Support Organization database showed only one documented use of pretransplant extracorporeal life support in biliary atresia.